Skip to main navigation Skip to search Skip to main content

Guideline adherence in ovarian cancer for surgical staging in the Netherlands

  • Nishita M S Baldewpersad Tewarie*
  • , Maaike van Ham
  • , the participants of the Dutch Gynecological Oncology Collaborator group
  • , Michel Wouters
  • , Roy Kruitwagen
  • , Willemien van Driel
  • *Corresponding author for this work
  • Radboud University Medical Center
  • Maastricht University Medical Centre
  • Netherlands Cancer Institute

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)

Abstract

Objective Previous studies have shown low adherence to surgical staging guidelines in patients with clinical early-stage ovarian carcinoma. The aim of this study was to identify guideline adherence for surgical staging and to show the distribution of each surgical item within the study population. In addition, we examined whether regional variation in the Netherlands exists for complete surgical staging. Methods Patients with ovarian cancer and surgical staging registered in the Dutch Gynecological Oncology Audit between January 1, 2015 and December 31, 2019 in the Netherlands were included. Complete surgical staging was defined according to the Dutch evidence-based guideline. Surgical items were ranked and illustrated. Variation in complete surgical staging for eight regional cancer networks was shown in funnel plots. Manual validation of registered data was performed in three gynecological oncology centers. Results 604 patients underwent surgical staging, 365 (60%) underwent an incomplete staging procedure, 295 (81%) were registered with early-stage disease (International Federation of Gynecology and Obstetrics I-IIA) and, of these patients, 115 (39%) received adjuvant chemotherapy. Patients with incomplete surgical staging were operated more often with minimal invasive techniques (laparoscopy or robot) compared with patients in the complete staging group (p<0.001). Sampling of cytology/ascites was the most frequently lacking factor (29%). Manual validation of data in three gynecological oncology centers identified reasons for incomplete staging, the most common being 'perioperative findings' such as dense adhesions between tumor and peritoneum, consistent with advanced stage disease (≥IIA). Regional variation for complete surgical staging showed two regions performing outside the confidence intervals (12.5% and 25.5%, mean 40%). Conclusion Guideline adherence for staging was lower than expected and validation of data gave additional insights into the reasons that were contributing to incomplete surgical staging. Moreover, this analysis showed that regional variation for surgical staging exists, which forms a starting point to improve and harmonize staging procedures for these patients nationwide.

Original languageEnglish
Pages (from-to)1592-1598
Number of pages7
JournalInternational Journal of Gynecological Cancer
Volume32
Issue number12
DOIs
Publication statusPublished - 21 Oct 2022

Bibliographical note

Publisher Copyright:
© IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Guideline adherence in ovarian cancer for surgical staging in the Netherlands'. Together they form a unique fingerprint.

Cite this